Search

Your search keyword '"Zorg en O' showing total 270 results

Search Constraints

Start Over You searched for: Author "Zorg en O Remove constraint Author: "Zorg en O
270 results on '"Zorg en O'

Search Results

101. The results of concentration of care: Surgical outcomes of neuroblastoma in the Netherlands

102. Questionnaire- and linkage-based outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER study part 1

103. Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm

104. Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients

105. Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer (Nature Medicine, (2023), 29, 6, (1340-1348), 10.1038/s41591-023-02339-y)

106. Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study

107. Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial

108. Organizational characteristics of European pediatric onco-critical care: An international cross-sectional survey

109. Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors

110. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols

111. Artificial Intelligence in Pediatric Pathology: The Extinction of a Medical Profession or the Key to a Bright Future?

112. The fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries

113. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma

114. Parents' experiences with large-scale sequencing for genetic predisposition in pediatric renal cancer: A qualitative study

115. Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'

116. Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy

117. MHC II - EGFP knock-in mouse model is a suitable tool for systems and quantitative immunology

118. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization

119. Progressive diastolic dysfunction in survivors of pediatric differentiated thyroid carcinoma

120. Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands

121. Body mass index at diagnosis of a childhood brain tumor; a reflection of hypothalamic-pituitary dysfunction or lifestyle?

122. Oncofertility Perspectives for Girls with Cancer

124. A Study on Prevalence and Determinants of Ototoxicity During Treatment of Childhood Cancer (SOUND): Protocol for a Prospective Study

125. Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

126. Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy

127. High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort

128. Fasting Intervention for Children With Unilateral Renal Tumors to Reduce Toxicity

129. Progress against non-Hodgkin's lymphoma in children and young adolescents in the Netherlands since 1990: Stable incidence, improved survival and lower mortality

130. Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year's experience of national centralization

131. Thyroid function after diagnostic I-123-metaiodobenzylguanidine in children with neuroblastic tumors

132. Support needs of Dutch young adult childhood cancer survivors

133. Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire--a DCCSS LATER study

135. Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS

136. MRI Characteristics of Pediatric Renal Tumors: A SIOP-RTSG Radiology Panel Delphi Study

137. MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance

138. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer

139. Overweight in the Dutch National Cohort of Long-Term Survivors of Childhood Cancer

140. Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer

141. Long-Term Effects of Childhood Cancer Treatment on Dentition and Oral Health: A Dentist Survey Study from the DCCSS LATER 2 Study

142. Locoregional Control Using Highly Conformal Flank Target Volumes and Volumetric-Modulated Arc Therapy in Pediatric Renal Tumors: Results from the Dutch National Cohort

143. Significant improvement in survival of advanced stage childhood and young adolescent cancer in the Netherlands since the 1990s

144. Characteristics and Outcome of Children with Renal Tumors in the Netherlands: First Five Year Single National Center Experience

145. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group

146. Prognostic factors for wilms tumor recurrence: A review of the literature

147. Inter-Clinician Delineation Variation for a New Highly-Conformal Flank Target Volume in Children with Renal Tumors: A Siop-Renal Tumor Study Group International Multicenter Exercise

148. Single cell derived mRNA signals across human kidney tumors

149. Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours

150. Interobserver variability between experienced and inexperienced observers in the histopathological analysis of Wilms tumors: a pilot study for future algorithmic approach

Catalog

Books, media, physical & digital resources